A discussion of the link between hearing loss and cardiovascular disease with Paul Mick, MD, and Anil K Lalwani, MD.

A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

A study has found that in patients with ischemic heart disease receiving ventricular tachycardia ablation there is higher risk of mortality.

Evidence of increased rates of cardiovascular disease (CVD) events and death during US wildfires is inconsistent between wildfires.

Age and hypertension are associated with increased risks for cranial ischemic complications in GCA, while anticoagulant therapy may offer protective benefits.

Maternal health in pregnancy is associated with offspring autism, and these associations are largely attributed to familial confounding.

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

GDR, compared with other insulin resistance markers, demonstrated superior predictive value for cardiovascular outcomes such as MI.

Macrolide maintenance therapy in patients with bronchiectasis significantly reduces the risk for major adverse cardiovascular events.

The pandemic expansion of Medicare telehealth services will expire March 31 unless Congress acts to extend or make permanent pandemic-era telehealth changes.

The number of US adults with severe obesity increased from 2013 to 2023, according to a research letter published online.

Between the 2017-2018 and 2023-2024 influenza seasons, the use of antiviral therapy in pediatric patients with influenza declined in both inpatient and outpatient settings.